Abstract
(380) - CTLA4Ig Administered During T-Cell Priming Suppresses De Novo Alloantibodies and Minimizes Recall Antibody Responses
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have